CClinicalTrials.gg
Active, not recruitingNCT03452007Updated Dec 13, 2024

SPARC Bladder Mapping and Training Study

An interventional study of Epidural Stimulation in Spinal Cord Injuries, sponsored by University of Louisville. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-13.

Sponsored by University of Louisville · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The investigators propose to determine the electrode configurations that promote functional gains in the storage and voiding phases of lower urinary tract function as a result of activation of spinal circuits with spinal cord epidural stimulation in humans with spinal cord injury. The innovative approach and novel application of the Medtronic Specify 5-6-5 (16-electrode array) epidural device will allow the investigators to determine, with this early feasibility study, specific parameters of spinal cord epidural stimulation and approaches for bladder training needed for lower urinary tract function which will lay the groundwork for expedient translation of this promising technology to larger numbers of individuals with spinal cord injury who currently have limited treatment options. The current proposed study will increase the understanding of human lumbosacral spinal networks and guide the use of innovative therapeutic strategies that would be immediately available to not only improve the motor output during standing and walking but also ameliorate bladder dysfunction and thus improve quality of life in individuals after spinal cord injury.

Read the detailed description

Deficits in urologic function after spinal cord injury impact quality of life and consistently ranks as a top priority issue in the spinal cord injury population. Bladder dysfunction may manifest as detrusor hyperreflexia (bladder contractions at low volumes, causing incontinence and smooth muscle hypertrophy), detrusor-sphincter dyssynergia (uncoordinated bladder and external urethral sphincter contractions, causing inefficient emptying and smooth muscle hypertrophy), decreased compliance (unable to store urine under appropriately low pressures) and loss of continence, requiring lifelong management, maintenance, and health care visits. Current therapeutic approaches aim to manage both the storage and voiding phases of bladder function and include intermittent catheterization, pharmacologic and surgical interventions. While most of these strategies are necessary for urological maintenance post-injury they oftentimes are associated with side effects and therefore remain inadequate. Therapies addressing recovery of function are still needed. The use of spinal cord epidural stimulation is a promising alternative approach to addressing the primary phases of bladder dysfunction. Additionally, the effects of spinal cord epidural stimulation on bladder alone is not known as its use has been directed towards the locomotor system. Thus, the overall objective of this study is to perform functional mapping in order to identify the spinal cord epidural stimulation configurations (anode/cathode selection, amplitude, frequency and pulse width) at the lumbosacral level that can promote neural control of bladder storage (capacity) and bladder emptying (voiding efficiency) after spinal cord injury.

02

Conditions studied

  • Spinal Cord Injuries

Keywords

  • Epidural Stimulation
  • Bladder dysfunction
  • Spinal cord injury
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • stable medical condition without cardiopulmonary disease or dysautonomia that would contraindicate bladder training;
  • clear indications that the period of spinal shock is concluded determined by presence of muscle tone, deep tendon reflexes or muscle spasms and discharged from standard inpatient rehabilitation;
  • non-progressive supra-sacral SCI (i.e., upper motor neuron re bladder circuitry);
  • AIS classification A or B;
  • at least 2 years post spinal cord injury.

Exclusion criteria

Exclusion Criteria:

  • Painful musculoskeletal dysfunction, unhealed fracture, contracture, pressure sore or urinary tract infection that might interfere with mapping/training;
  • Clinically significant depression or ongoing drug abuse;
  • Pregnant at the time of enrollment or planning to become pregnant during the time course of the study
  • Bladder Botox injections within the past year;
  • Continent diversion procedures with or without bladder augmentation.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    Bladder Mapping and Training

    Individuals already implanted or newly implanted with a spinal cord epidural stimulator will receive epidural stimulation targeted at enhancing both the storage and voiding phase of micturition cycle.

    Device: Epidural Stimulation

Interventions

  • DeviceEpidural Stimulation

    Spinal cord epidural stimulation will be administered through a multi-electrode array implanted in the epidural space over the dorsum of the spinal cord. An implanted package containing stimulating circuits, rechargeable battery, and wireless communication activates the electrodes (16 platinum electrodes arranged in three columns of \[5-6-5\]). The pattern of electrically active electrodes, as well as electrode voltage, stimulating frequency, and stimulating pulse width will be varied to facilitate effects toward bladder function.

05

What researchers measure

Primary outcomes

  1. Changes in bladder volume during filling cystometry at low filling pressures

    The quantitative metric will be the percent changes in either residual volume (measured in ml) alone if no leak occurred or leak volume divided by leak plus residual volumes if a void occurred upon reaching capacity.

    Time frame: 2 years

Secondary outcomes

  1. Changes in Sexual Function

    International SCI Data Set Questionnaire for Sexual Function

    Time frame: 2 years

  2. Changes in Bowel Function

    International SCI Data Set Questionnaire for Bowel Function

    Time frame: 2 years

  3. Changes in Systolic Blood Pressure

    Percent change without versus with epidural stimulation

    Time frame: 2 years

Other outcomes

  1. Changes in Renal Bladder Ultrasound

    Measurements include kidney dimensions, parenchymal thickness, renal and aortic velocities, bladder size and thickness.

    Time frame: 2 years

06

Study locations

1 site
  • University of Louisville
    Louisville, Kentucky 40202, United States
07

References and documents

Study documents

  • Informed consent form · Sep 12, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03452007
Lead sponsor
University of Louisville
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Susan Harkema PhD (Professor, University of Louisville) — Principal investigator
First posted
Mar 2, 2018
Start date
Sep 12, 2018
Primary completion
Aug 31, 2024
Completion
Dec 31, 2025 (estimated)
Last update
Dec 13, 2024

Study contacts

Susan Harkema, PhD
principal investigator · University of Louisville

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion